دورية أكاديمية

Metabolism of megestrol acetate in vitro and the role of oxidative metabolites.

التفاصيل البيبلوغرافية
العنوان: Metabolism of megestrol acetate in vitro and the role of oxidative metabolites.
المؤلفون: House, Larry, Seminerio, Michael J., Mirkov, Snezana, Ramirez, Jacqueline, Skor, Maxwell, Sachleben, Joseph R., Isikbay, Masis, Singhal, Hari, Greene, Geoffrey L., Vander Griend, Donald, Conzen, Suzanne D., Ratain, Mark J.
المصدر: Xenobiotica; Oct2018, Vol. 48 Issue 10, p973-983, 11p
مصطلحات موضوعية: DRUG metabolism, CYTOCHROME P-450, DRUG approval, GLUCURONOSYLTRANSFERASE, NICOTINAMIDE adenine dinucleotide phosphate
مستخلص: 1. There is limited knowledge regarding the metabolism of megestrol acetate (MA), as it was approved by FDA in 1971, prior to the availability of modern tools for identifying specific drug-metabolizing enzymes. We determined the cytochrome P450s (P450s) and UDP-glucuronosyltransferases (UGTs) that metabolize MA, identified oxidative metabolites and determined pharmacologic activity at the progesterone, androgen and glucocorticoid receptors (PR, AR and GR, respectively). 2. Oxidative metabolites were produced using human liver microsomes (HLMs), and isolated for mass spectral (MS) and nuclear magnetic resonance (NMR) analyses. We screened recombinant P450s using MA at 62 μM (HLM Km for metabolite 1; M1) and 28 μM (HLM Km for metabolite 2; M2). UGT isoforms were simultaneously incubated with UDPGA, nicotinamide adenine dinucleotide phosphate (NADPH), CYP3A4 and MA. Metabolites were evaluated for pharmacologic activity on the PR, AR and GR. CYP3A4 and CYP3A5 are responsible for oxidative metabolism of 62 μM MA. 3. At 28 μM substrate concentration, CYP3A4 was the only contributing enzyme. Mass spectral and NMR data suggest metabolism of MA to two alcohols. After oxidation, MA is converted into two secondary glucuronides by UGT2B17 among other UGTs. MA, M1 and M2 had significant pharmacologic activity on the PR while only MA showed activity on the AR and GR. [ABSTRACT FROM AUTHOR]
Copyright of Xenobiotica is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:00498254
DOI:10.1080/00498254.2017.1386335